drugset / Trial / NCT01574638

Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults

NCT01574638

RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate two different ways to give rifapentine (RPT), a drug that may help shorten treatment duration for tuberculosis (TB) disease.

Timeline

Start
2012-06
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Rifapentine Small molecule 10 mg/kg Oral
Subject Rifapentine Small molecule 15 mg/kg Oral
Subject Rifapentine Small molecule 20 mg/kg Oral

Indications